Columbia/HCA puts ValueRx up for sale three weeks after completing purchase of PBM.
Executive Summary
COLUMBIA/HCA PUTS VALUERx BACK UP FOR SALE as part of divestment plans adopted by new management following the indictment of three company officials for alleged Medicare fraud. Just three weeks after completing the $1.1 bil. acquisition of Value Health, Columbia/HCA has decided to divest three of the company's four lines of business, including the ValueRx pharmacy benefit management company.